VAH Delivered Its Second New Airbus A220-300 in 2022 and Announces Five More A220 Aircraft Under Sale and Leaseback
STAMFORD, Conn.–(BUSINESS WIRE)–Voyager Aviation Holdings, LLC (“VAH,” the “Company”) announced that the Company has recently…
STAMFORD, Conn.–(BUSINESS WIRE)–Voyager Aviation Holdings, LLC (“VAH,” the “Company”) announced that the Company has recently…
The Fifth in Its Acquisition Spree of Security Technology Companies and Brands PASADENA, Calif.–(BUSINESS WIRE)–#acquisition–RealDefense…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a research report examining bank earnings during the past several years,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Kurt Hediger’s arrival bolsters GCA’s industrial capital markets nationwide NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Graystone Capital Advisors,…
NEWTON, Mass.–(BUSINESS WIRE)–Global technology media and purchase intent data and services company TechTarget, Inc. (Nasdaq:…
Leading Customer Data and Experience Platform (CDXP) company continues enhancing car buying and ownership journey…
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:…
LB101 is a conditionally tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibody being developed for solid tumors BOSTON…
BOSTON, Jan. 26, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharma company focused…
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela” or the…
CEO Gregory Gorgas to discuss developments related to the Company’s Cancer Appetite Recovery Study (CAReS) Presentation…
MIAMI, FL, Jan. 26, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company…
BOTHELL, Wash., Jan. 26, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the…
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
REDWOOD CITY, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
BALTIMORE, Jan. 26, 2023 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused…
FLORHAM PARK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Phase 2 clinical trials of VTX958 (TYK2 inhibitor) in plaque psoriasis, Crohn’s disease and psoriatic…
PHOENIX, Jan. 26, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative…